港股異動 | 維他奶(0345.HK)跌近4% 昨日遭沽空機構狙擊
格隆匯1月17日丨昨日上午沽空機構Valiant Varriors發報告指控維他奶國際(0345.HK)涉嫌“財務欺詐”,嚴重誇大其中國及澳洲業務利潤及資本支出、現金流不佳,揚言維他奶股價只值10港元,有潛在逾60%的跌幅。隨後維他奶發公告指,董事會強烈否認沽空報告指控,並認為該等指控並不準確及具誤導性。保留對Valiant Varriors及相關負責人士採取法律行動之權利,公司將於適當時候另行發表公告,澄清及處理該報告所提出有關指控。維他奶股價昨日午後不跌反漲,最終收漲於5.6%,收報29.25港元。不過,該股今日平開低走,現報28.1港元,跌3.93%,暫成交1.3億港元,最新總市值298.9億港元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.